Updated on 6 September 2012
What are the major benefits of this technology?
EndoBarrier Therapy has been clinically shown to lower HbA1c levels, achieve weight loss of more than 20 percent within one year, and improve important metabolic functions, including cholesterol, blood pressure and triglycerides. Food bypasses the duodenum and proximal jejunum as it does in a gastric bypass procedure, but the EndoBarrier has distinct advantages over surgical therapies:
Clinical trial experience to date involving more than 500 patients has demonstrated significant diabetes improvement and weight loss with EndoBarrier Therapy. In addition, while receiving EndoBarrier Therapy, many patients are also able to decrease their dosage of oral anti-diabetes medications.
Share with us some of the results from the clinical trials that were conducted prior to commercialization of the therapy.
In 13 clinical trials involving more than 500 patients, EndoBarrier Therapy has been shown to lower HbA1c (blood glucose) levels, achieve weight loss of more than 20 percent and improve important metabolic functions including cholesterol, blood pressure and triglycerides within a year.